Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125485652 | 12548565 | 2 | F | 20160729 | 20160712 | 20160809 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-42356BP | BOEHRINGER INGELHEIM | 0.00 | M | Y | 68.04000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125485652 | 12548565 | 1 | PS | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | U | 20579 | ||||||||||
125485652 | 12548565 | 2 | C | CIALIS | TADALAFIL | 1 | Unknown | 0 | 100 | MG | |||||||||
125485652 | 12548565 | 3 | C | CIALIS | TADALAFIL | 1 | 0 | ||||||||||||
125485652 | 12548565 | 4 | C | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 100 MG | 0 | 100 | MG | TABLET | QD | ||||||
125485652 | 12548565 | 5 | C | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | STRENGTGH: 100 MG | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125485652 | 12548565 | 1 | Product used for unknown indication |
125485652 | 12548565 | 2 | Bladder discomfort |
125485652 | 12548565 | 3 | Calculus prostatic |
125485652 | 12548565 | 4 | Urinary retention |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125485652 | 12548565 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |